[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- Sponsor Message [Copper Exploration Heating Up](=) [Discover the Opportunities in the New Copper Hotspot](=) --------------------------------------------------------------- November 15, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Huge Upside Potential With "Staggering" Solar Demand](=) solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth. [See How Investors Could Benefit](=) = --------------------------------------------------------------- [4D Molecular Therapeutics, FDMT](=) Recent Analyst Action: Joshua Schimmer, analyst at Evercore ISI, reiterates coverage on [4D Molecular Therapeutics (FDMT)](=)in the Healthcare sector with a Buy rating and a price target of $45.00 (1 day ago). - Recent Price: $16.75 - Average Analyst Price Target: $28.33 (69.13%) - Market Cap: $405.23M [TipRanks.com](=) also reports that [4D Molecular Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $28.33. The target pricing ranges from a high forecast of $45.00 down to a low forecast of $15.00. [4D Molecular Therapeutics (FDMT)](’s last closing price was $16.75 which would put the average price target at $28.33. Here are 3rd party ratings for [FDMT](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 36% (91 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Get Your Money Out of U.S. Banks Immediately]( A historic financial reset in 2023 could soon result in a run on the banks. Get out of cash and into a new vehicle 50 years in the making. [MORE HERE](=) --------------------------------------------------------------- [Outset Medical, OM](=) Recent Analyst Action: Shagun Singh, analyst at RBC Capital, reiterates coverage on [Outset Medical (OM)](=)in the Healthcare sector with a Buy rating and a price target of $23.00 (4 days ago). - Recent Price: $19.78 - Average Analyst Price Target: $22.75 (15.02%) - Market Cap: $863.74M [TipRanks.com](=) also reports that [Outset Medical](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.75. The target pricing ranges from a high forecast of $29.00 down to a low forecast of $17.00. [Outset Medical (OM)](=)’s last closing price was $19.78 which would put the average price target at $22.75. Here are 3rd party ratings for [OM](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Top 34% (86 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- [Tenaya Therapeutics, TNYA]( Recent Analyst Action: Geulah Livshits, analyst at Chardan Capital, reiterates coverage on [Tenaya Therapeutics (TNYA)](=)in the Healthcare sector with a Buy rating and a price target of $28.00 (4 days ago). - Recent Price: $3.05 - Average Analyst Price Target: $24.50 (703.28%) - Market Cap: $110.47M [TipRanks.com]() also reports that [Tenaya Therapeutics](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $24.50. The target pricing ranges from a high forecast of $28.00 down to a low forecast of $21.00. [Tenaya Therapeutics (TNYA)](=)’s last closing price was $3.05 which would put the average price target at $24.50. Here are 3rd party ratings for [TNYA](=): - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 25% (62 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Click here]( for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [Quanterix, QTRX](=) Recent Analyst Action: Matthew Sykes, analyst at Goldman Sachs, reiterates coverage on [Quanterix (QTRX)](=)in the Healthcare sector with a Hold rating and a price target of $13.00 (5 days ago). - Recent Price: $13.12 - Average Analyst Price Target: $13.75 (4.80%) - Market Cap: $469.85M [TipRanks.com]() also reports that [Quanterix](=)currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $13.75. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $12.00. [Quanterix (QTRX)](’s last closing price was $13.12 which would put the average price target at $13.75. Here are 3rd party ratings for [QTRX](=): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 36% (161 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- [Avita Medical, RCEL]( Recent Analyst Action: Ryan Zimmerman, analyst at BTIG, reiterates coverage on [Avita Medical (RCEL)]()in the Healthcare sector with a Buy rating and a price target of $16.00 (5 days ago). - Recent Price: $7.5 - Average Analyst Price Target: $13.50 (80.00%) - Market Cap: $175.22M [TipRanks.com](=) also reports that [Avita Medical](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.50. The target pricing ranges from a high forecast of $16.00 down to a low forecast of $11.00. [Avita Medical (RCEL)](’s last closing price was $7.5 which would put the average price target at $13.50. Here are 3rd party ratings for [RCEL](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 36% (91 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [How High Can Copper Go?]() power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go? [Find Out in this Research Report.]( --------------------------------------------------------------- [Olaplex Holdings, OLPX](=) Recent Analyst Action: Dara Mohsenian, analyst at Morgan Stanley, reiterates coverage on [Olaplex Holdings (OLPX)](=)in the Consumer Goods sector with a Hold rating and a price target of $6.00 (5 days ago). - Recent Price: $6.15 - Average Analyst Price Target: $8.64 (40.49%) - Market Cap: $3.77B [TipRanks.com]() also reports that [Olaplex Holdings]()currently has 12 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $8.64. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $5.00. [Olaplex Holdings (OLPX)]()’s last closing price was $6.15 which would put the average price target at $8.64. Here are 3rd party ratings for [OLPX](): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 29% (179 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- [Flux Power Holdings, FLUX](=) Recent Analyst Action: Amit Dayal, analyst at H.C. Wainwright, reiterates coverage on [Flux Power Holdings (FLUX)]()in the Services sector with a Buy rating and a price target of $15.00 (4 days ago). - Recent Price: $5 - Average Analyst Price Target: $10.50 (110.00%) - Market Cap: $75.51M [TipRanks.com]() also reports that [Flux Power Holdings]()currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.50. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $6.00. [Flux Power Holdings (FLUX)](=)’s last closing price was $5 which would put the average price target at $10.50. Here are 3rd party ratings for [FLUX](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 35% (89 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [New "Vertical" Technology Solves Solar Power's Major Flaw]( conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive... Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power. [See How Early Stage Investors in This Solar Tech Could Benefit]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808